Semarion
PrivateLast Round
VC Round
Mar 31, 2026
Total Funding Raised
$3.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Semarion is a life sciences company that has developed the SemaCyte® platform, a microcarrier technology using materials engineering to accelerate adherent cell screening for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Semarion Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Semarion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 31, 2026 | ||||
| VC Round | Mar 17, 2025 | ||||
| Seed | Feb 22, 2022 | ||||
| Pre Seed | Jun 22, 2020 |
Key People
Founding team and executive leadership
Semarion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Found Capital | VC Round |
| Start Codon | VC Round, Pre Seed |
| Cambridge Capital Group | VC Round |
| Cambridge Enterprise | VC Round |
| The FSE Group | VC Round |
| Found Capital | VC Round |
| Parkwalk Advisors | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
$3.8M raised in Seed round.
- Feb 22, 2022
$2.89M round led by Parkwalk Advisors.
Semarion Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Semarion's valuation, stock price, and market status.